Kerbside

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation

UPWARD TRAJECTORY 

Alembic Limited BSE
Code : 506235
CMP : Rs 102.25

The company operates in the pharmaceuticals and real estate sectors. In pharmaceuticals it focuses on manufacturing and marketing of fermentation and chemistry-based active pharmaceuticals ingredients while in real estate it is engaged in the construction of residential and commercial projects as well as project management and marketing consultancy. One of the leading brokerage houses is quite bullish on this stock and has been recommending it to its prime clients. The main reason could be that the stock has broken out of its six-year range in June 2020. After this range breakout, the stock has seen a sharp run-up of nearly 30 per cent and has been making higher tops and higher bottoms for the past 11 weeks. Also, the target of this breakout is quite high. Hence, traders with risk appetite can check this stock for quick gains. 

WAITING IN THE WINGS 

Reliance Industries
BSE Code : 500325
CMP : Rs 2161.25 

The crown jewel of Nifty 50 index, Reliance Industries, which after a massive move from the March lows, has retreated into a shell over the last couple of weeks. As per some market dealers, the stock has been witnessing good accumulation and if the rumours are to be believed there is some big development announcement in the offing that could induce big movement in the stock. So, it’s better to invest before it’s too late! 

TECHNICALLY STABLE 

Poly Medicure
BSE Code : 531768
CMP : Rs 478.50 

Poly Medicure is one of the leading medical devices manufacturer and exporters in India with a dominant position in the medical consumables market. In fact, it is one of the fastest growing medical devices company in India. The company’s business distribution among its various product categories is as follow: infusion therapy and vascular access (71 per cent), blood transfusion (9 per cent), surgery and wound drainage (5 per cent), renal (4 per cent), anaesthesia and respiratory range (3 per cent) and others (8 per cent). From a technical viewpoint, the stock has been trading comfortably above the important moving averages i.e. 50 and 200 DMA. Furthermore, the stock is meeting all the criteria of CANSLIM methodology and also Warren Buffett’s criteria for investing. It is therefore a perfect combination of technical and fundamental pick and investors can buy the scrip for decent returns in the short to medium term. 

POLISHED TO PERFECTION 

Asian Granito India
BSE Code : 532888
CMP : Rs 288.40

Asian Granito India is one of the top tile manufacturers in India. In Q1FY21, revenue from its various segments has been as follows: tiles (87 per cent), marble (4 per cent), quartz (5 per cent), power grace (1 per cent) and others and sanitary ware (3 per cent). Q1FY20 for the company remained subdued due to supply chain disruption and phase-wise unlocking of the cities. Demand from project business continues to see a slowdown. However, the company is seeing some green shoots in demand, especially from rural, semi-urban and retail sales. And the demand from these segments is likely to further improve from the current levels which would result in an increase in revenue in the coming quarters. Risk-takers can go for this scrip and hope to make a quick buck. 

(Closing price as of September 09, 2020)